Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Alar Pharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price

NT$169

2024-10-29

Market Capitalization

NT$11.1 B

2024-10-29

Revenue

NT$2.8 M

FY, 2025

CreditSafe Score

?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

TWDFY, 2018FY, 2019FY, 2020FY, 2021FY, 2022FY, 2023FY, 2024FY, 2025
Revenue500.0K600.0K800.0K469.3M5.8M2.8M
Cost of goods sold2.0M613.0K
Gross profit500.0K26.9M5.0K806.0K469.3M4.3M2.8M
Gross profit margin, %100.0%4479.3%100.8%100.0%74.3%101.2%
Operating expense total69.4M58.2M168.5M89.9M44.1M80.4M67.9M165.1M
Depreciation and amortization2.0M13.7M2.8M3.4M3.2M3.4M3.9M4.9M
EBITDA(68.9M)(58.2M)(141.6M)(89.9M)(43.3M)388.9M(72.1M)(163.0M)
EBITDA margin, %-13780.0%-23607.7%-5414.4%82.9%-1239.0%-5921.9%
EBIT(54.2M)(69.1M)(144.5M)(65.8M)(37.0M)385.6M(76.0M)(167.9M)
EBIT margin, %-10842.0%-24081.5%-4621.6%82.2%-1305.7%-6098.7%
Interest income446.0K1.1M1.6M1.5M2.8M16.9M66.3M54.5M
Interest expense44.0K33.0K21.0K22.0K63.0K27.0K81.0K
Pre tax profit(53.8M)(68.0M)(142.8M)(64.2M)(32.5M)391.1M37.0M(79.0M)
Income tax expense12.7M8.5M18.9M712.0K
Net Income(53.8M)(68.0M)(142.8M)(64.2M)(45.2M)382.6M18.2M(79.7M)

Footer menu